# A Pharmacokinetic Study Comparing EG12014 and Herceptin (Trastuzumab) in Healthy Male Volunteers

> **NCT03180242** · PHASE1 · COMPLETED · sponsor: **EirGenix, Inc.** · enrollment: 84 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** EG12014
- **BIOLOGICAL:** EU-sourced Herceptin
- **BIOLOGICAL:** US-sourced Herceptin

## Key facts

- **NCT ID:** NCT03180242
- **Lead sponsor:** EirGenix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-22
- **Primary completion:** 2016-08-22
- **Final completion:** 2016-08-22
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03180242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03180242, "A Pharmacokinetic Study Comparing EG12014 and Herceptin (Trastuzumab) in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03180242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*